#BEGIN_DRUGCARD DB01985

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C8H16N4O3

# Chemical_IUPAC_Name:
(2S)-5-carbamimidamido-2-acetamidopentanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
N-Alpha-L-Acetyl-Arginine

# HET_ID:
AAG

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C8H16N4O3/c1-5(13)12-6(7(14)15)3-2-4-11-8(9)10/h6H,2-4H2,1H3,(H,12,13)(H,14,15)(H4,9,10,11)/t6-/m0/s1

# InChI_Key:
InChIKey=SNEIUMQYRCDYCH-LURJTMIESA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1985

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
216.2376

# Molecular_Weight_Mono:
216.122240398

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1DRY

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.7

# Predicted_LogS:
-2.5

# Predicted_Water_Solubility:
7.67e-01 g/l

# Primary_Accession_No:
DB01985

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
67427

# PubChem_Substance_ID:
46508435

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00382

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(=O)N[C@@H](CCCNC(N)=N)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:41 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
L06213

# Drug_Target_1_GenBank_ID_Protein:
153220

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
cs1

# Drug_Target_1_Gene_Sequence:
>975 bp
ATGACCTCAGTGGACTGCACCGCGTACGGCCCCGAGCTGCGCGCGCTCGCCGCCCGGCTG
CCCCGGACCCCCCGGGCCGACCTGTACGCCTTCCTGGACGCCGCGCACACAGCCGCCGCC
TCGCTCCCCGGCGCCCTCGCCACCGCGCTGGACACCTTCAACGCCGAGGGCAGCGAGGAC
GGCCATCTGCTGCTGCGCGGCCTCCCGGTGGAGGCCGACGCCGACCTCCCCACCACCCCG
AGCAGCACCCCGGCGCCCGAGGACCGCTCCCTGCTGACCATGGAGGCCATGCTCGGACTG
GTGGGCCGCCGGCTCGGTCTGCACACGGGGTACCGGGAGCTGCGCTCGGGCACGGTCTAC
CACGACGTGTACCCGTCGCCCGGCGCGCACCACCTGTCCTCGGAGACCTCCGAGACGCTG
CTGGAGTTCCACACGGAGATGGCCTACCACCGGCTCCAGCCGAACTACGTCATGCTGGCC
TGCTCCCGGGCCGACCACGAGCGCACGGCGGCCACACTCGTCGCCTCGGTCCGCAAGGCG
CTGCCCCTGCTGGACGAGAGGACCCGGGCCCGGCTCCTCGACCGGAGGATGCCCTGCTGC
GTGGATGTGGCCTTCCGCGGCGGGGTGGACGACCCGGGCGCCATCGCCCAGGTCAAACCG
CTCTACGGGGACGCGGACGATCCCTTCCTCGGGTACGACCGCGAGCTGCTGGCGCCGGAG
GACCCCGCGGACAAGGAGGCCGTCGCCGCCCTGTCCAAGGCGCTCGACGAGGTCACGGAG
GCGGTGTATCTGGAGCCCGGCGATCTGCTGATCGTCGACAACTTCCGCACCACGCACGCG
CGGACGCCGTTCTCGCCCCGCTGGGACGGGAAGGACCGCTGGCTGCACCGCGTCTACATC
CGCACCGACCGCAATGGACAGCTCTCCGGCGGCGAGCGCGCGGGCGACGTCGTCGCCTTC
ACACCGCGCGGCTGA

# Drug_Target_1_General_Function:
Involved in oxidoreductase activity

# Drug_Target_1_General_References:
1472501	Marsh EN, Chang MD, Townsend CA: Two isozymes of clavaminate synthase central to clavulanic acid formation: cloning and sequencing of both genes from Streptomyces clavuligerus. Biochemistry. 1992 Dec 22;31(50):12648-57.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2400

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
35370

# Drug_Target_1_Name:
Clavaminate synthase 1

# Drug_Target_1_Number_of_Residues:
324

# Drug_Target_1_PDB_ID:
1GVG

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02668	TauD

# Drug_Target_1_Protein_Sequence:
>Clavaminate synthase 1
MTSVDCTAYGPELRALAARLPRTPRADLYAFLDAAHTAAASLPGALATALDTFNAEGSED
GHLLLRGLPVEADADLPTTPSSTPAPEDRSLLTMEAMLGLVGRRLGLHTGYRELRSGTVY
HDVYPSPGAHHLSSETSETLLEFHTEMAYHRLQPNYVMLACSRADHERTAATLVASVRKA
LPLLDERTRARLLDRRMPCCVDVAFRGGVDDPGAIAQVKPLYGDADDPFLGYDRELLAPE
DPADKEAVAALSKALDEVTEAVYLEPGDLLIVDNFRTTHARTPFSPRWDGKDRWLHRVYI
RTDRNGQLSGGERAGDVVAFTPRG

# Drug_Target_1_Reaction:
(1) deoxyamidinoproclavaminate + 2-oxoglutarate + O2 = amidinoproclavaminate + succinate + CO2

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Deoxyamidinoproclavaminate + 2-oxoglutarate + O(2) = amidinoproclavaminate + succinate + CO(2) + H(2)O

# Drug_Target_1_SwissProt_ID:
Q05581

# Drug_Target_1_SwissProt_Name:
CAS1_STRCL

# Drug_Target_1_Synonyms:
CAS1
CS1
Clavaminic acid synthetase 1
EC 1.14.11.21

# Drug_Target_1_Theoretical_pI:
5.24

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasmic

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AF098954

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
agaA

# Drug_Target_2_Gene_Sequence:
>1620 bp
ATGAAAAAAAATTATCTTTTACTGTATTTTATTTTTCTTTTGTGTGGCTCTATCGCTGCA
CAGGACTGGAACGGAATTCCTGTACCTGCCAATCCCGGAAATGGTATGACTTGGCAATTA
CAGGATAATGTTTCGGATAGTTTTAATTACACAAGTAGTGAAGGAAATAGGCCTACTGCC
TTTACTAGTAAATGGAAACCTTCCTATATCAATGGATGGACTGGTCCTGGATCAACAATT
TTTAATGCCGCGCAGGCATGGACCAATGGTTCTCAATTGGCAATTCAGGCACAACCAGCA
GGGAATGGAAAATCTTACAACGGAATTATCACCTCCAAAAATAAGATCCAGTACCCGGTG
TATATGGAAATTAAGGCCAAGATAATGGACCAGGTACTAGCAAATGCTTTCTGGACCTTG
ACTGACGACGAGACTCAGGAAATTGATATTATGGAAGGCTATGGCAGTGATCGGGGGGGA
ACTTGGTTCGCCCAAAGAATGCATTTGAGCCACCATACATTTATTCGTAACCCCTTTACG
GATTATCAGCCTATGGGAGACGCTACATGGTATTACAACGGAGGTACACCATGGCGTTCA
GCATATCACCGTTATGGATGTTATTGGAAAGATCCATTTACATTGGAATATTATATTGAC
GGGGTAAAGGTTAGAACGGTCACAAGAGCCGAAATTGATCCTAATAATCATCTCGGCGGA
ACAGGGTTGAATCAGGCAACAAATATTATTATTGATTGTGAAAATCAAACAGATTGGAGG
CCCGCGGCTACTCAAGAAGAACTGGCCGATGATAGCAAAAATATCTTCTGGGTCGATTGG
ATACGTGTGTACAAGCCTGTTGCGGTAAGTGGAGGTGGAAACAACGGTAACGACGGTGCC
ACTGAATTTCAATATGATTTAGGAACGGACACCTCGGCAGTATGGCCAGGGTATACACGG
GTTTCCAACACCACTAGGGCTGGTAATTTTGGATGGGCGAACACCAATGACATCGGATCA
AGAGATCGTGGGGCTTCTAACGGAAGGAACAATATAAACCGTGATATTAATTTTAGTTCA
CAAACTAGGTTCTTCACTCAAGACCTATCCAATGGCACTTATAACGTATTGATCACTTTT
GGGGACACCTATGCCCGAAAAAATATGAACGTCGCGGCCGAAGGGCAAAATAAATTAACA
AACATAAACACCAATGCCGGGCAATATGTTAGTAGGTCGTTTGACGTAAATGTCAACGAC
GGAAAACTAGATTTGCGATTTTCAGTTGGTAATGGCGGGGATGTGTGGTCCATTACAAGA
ATCTGGATTAGAAAAGTTACGAGCAACAGCGCTAATTTGTTAGCGGCAAAAGGATTAACA
TTGGAAGATCCTGTGGAAACTACGGAATTTTTATATCCTAACCCCGCAAAAACAGATGAT
TTTGTGACTGTTCCCAATAGTGAAATTGGAAGTAGTATAATCATCTATAATAGTGCAGGT
CAAGTAGTGAAAAAAGTAAGTGTGGTTTCCGAAAATCAGAAAATATCACTAGAAGGATTT
GCTAAAGGAATGTACTTTATCAATTTGAATGGTCAGAGTACAAAACTTATTGTCCAATAA

# Drug_Target_2_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_2_General_References:
12970344	Allouch J, Jam M, Helbert W, Barbeyron T, Kloareg B, Henrissat B, Czjzek M: The three-dimensional structures of two beta-agarases. J Biol Chem. 2003 Nov 21;278(47):47171-80. Epub 2003 Sep 11.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
4561

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
59994

# Drug_Target_2_Name:
Beta-agarase A

# Drug_Target_2_Number_of_Residues:
539

# Drug_Target_2_PDB_ID:
1O4Y

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00722	Glyco_hydro_16

# Drug_Target_2_Protein_Sequence:
>Beta-agarase A
MKKNYLLLYFIFLLCGSIAAQDWNGIPVPANPGNGMTWQLQDNVSDSFNYTSSEGNRPTA
FTSKWKPSYINGWTGPGSTIFNAAQAWTNGSQLAIQAQPAGNGKSYNGIITSKNKIQYPV
YMEIKAKIMDQVLANAFWTLTDDETQEIDIMEGYGSDRGGTWFAQRMHLSHHTFIRNPFT
DYQPMGDATWYYNGGTPWRSAYHRYGCYWKDPFTLEYYIDGVKVRTVTRAEIDPNNHLGG
TGLNQATNIIIDCENQTDWRPAATQEELADDSKNIFWVDWIRVYKPVAVSGGGNNGNDGA
TEFQYDLGTDTSAVWPGYTRVSNTTRAGNFGWANTNDIGSRDRGASNGRNNINRDINFSS
QTRFFTQDLSNGTYNVLITFGDTYARKNMNVAAEGQNKLTNINTNAGQYVSRSFDVNVND
GKLDLRFSVGNGGDVWSITRIWIRKVTSNSANLLAAKGLTLEDPVETTEFLYPNPAKTDD
FVTVPNSEIGSSIIIYNSAGQVVKKVSVVSENQKISLEGFAKGMYFINLNGQSTKLIVQ

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
1-19

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
Q9RGX9

# Drug_Target_2_SwissProt_Name:
Q9RGX9_ZOBGA

# Drug_Target_2_Synonyms:
Beta-agarase A precursor
EC 3.2.1.81

# Drug_Target_2_Theoretical_pI:
5.78

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB01985
